Cite
HARVARD Citation
Sandmaier, B. et al. (2019). Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. Lancet. 6 (8), pp. e409-e418. [Online].